BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11 mutation

BerGenBio ASA Norway

View original content:https://www.prnewswire.co.uk/news-releases/bergenbio-announces-initiation-of-phase-2a-in-first-line-non-small-lung-cancer-patients-with-a-stk11-mutation-302094991.html